Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 171,171 | 183,105 | 191,840 | 174,414 | 170,528 |
| Cost of Goods | 100,849 | 97,435 | 93,194 | 87,924 | 85,277 |
| Gross Profit | 70,322 | 85,670 | 98,646 | 86,490 | 85,251 |
| Operating Expenses | 57,541 | 50,499 | 73,520 | 45,230 | 48,235 |
| Operating Income | 13,630 | 35,606 | 25,320 | 42,184 | 37,293 |
| Interest Expense | 6,553 | 6,630 | 6,284 | 6,281 | 6,286 |
| Other Income | 2,975 | 2,938 | 2,477 | 3,432 | -145 |
| Pre-tax Income | 10,052 | 31,914 | 21,513 | 39,335 | 30,862 |
| Income Tax | 3,632 | 7,485 | 4,163 | 8,305 | 5,577 |
| Net Income Continuous | 6,420 | 24,429 | 17,350 | 31,030 | 25,285 |
| Net Income | $6,420 | $24,429 | $17,350 | $31,030 | $25,285 |
| EPS Basic Total Ops | 0.14 | 0.53 | 0.38 | 0.66 | 0.53 |
| EPS Basic Continuous Ops | 0.14 | 0.53 | 0.37 | 0.66 | 0.53 |
| EPS Diluted Total Ops | 0.14 | 0.51 | 0.37 | 0.64 | 0.51 |
| EPS Diluted Continuous Ops | 0.14 | 0.52 | 0.36 | 0.64 | 0.51 |
| EPS Diluted Before Non-Recurring Items | 0.26 | 0.61 | 0.83 | 0.75 | 0.61 |
| EBITDA(a) | $28,739 | $50,813 | $40,334 | $57,642 | $51,664 |